Robert A. Lefkowitz

5.2k citations
69 papers · 3.0k · 2 hit papers · h-index 28

Impact in

    • Sarcoma Diagnosis and Treatment
    • Renal cell carcinoma treatment
    • Gastric Cancer Management and Outcomes
    • Soft tissue tumor case studies
    • Bone Tumor Diagnosis and Treatments

Papers in

Robert A. Lefkowitz

66 papers receiving 2.9k citations

Robert A. Lefkowitz's Hit Papers

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates 2022 · 110 citations
1100+2+4Years since publication50100150200250

Peers

Robert A. Lefkowitz
Comparison fields: 5 of 89
  • Pulmonary and Respiratory Medicine 1.5k
  • Rheumatology 461
  • Oncology 792
  • Radiology, Nuclear Medicine and Imaging 403
  • Otorhinolaryngology 71
Replace Mercè Jordà with:
Mercè Jordà United States
A.M. Cassoni United Kingdom
Christopher L. Hallemeier United States
A.M. Mandard France
Stanley L. Liauw United States
G. Créhange France
Mustafa Beneklı Türkiye
Chang‐Ok Suh South Korea
Bernd Kasper Germany
Do Hoon Lim South Korea
Robert A. Lefkowitz relative to Mercè Jordà United States Mercè Jordà's profile →
Citations per field
00.5×2.5×
Mercè Jordà · 1×
Citations per year

Countries citing papers authored by Robert A. Lefkowitz

Since Specialization
Citations

This map shows the geographic impact of Robert A. Lefkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Lefkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Lefkowitz more than expected).

Fields of papers citing papers by Robert A. Lefkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Lefkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Lefkowitz. The network helps show where Robert A. Lefkowitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Lefkowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Lefkowitz Line = papers co-authored together Robert A. Lefkowitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Hit paper breakdown →
2020278
2 2009271
3 2007250
4 2011190
5 2010157
6 2011122
7
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates
Hit paper breakdown →
2022110
8 2006109
9 201099
10 201397
11 200787
12 200586
13 200783
14 201279
15 199368
16 200766
17 200852
18 201546
19 200744
20 202041

About Robert A. Lefkowitz

Robert A. Lefkowitz is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Rheumatology and Surgery, having authored 69 papers that have together received 3.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (15 papers), Renal cell carcinoma treatment (8 papers), Vascular Tumors and Angiosarcomas (5 papers), Cardiac tumors and thrombi (4 papers), Renal and related cancers (4 papers), Melanoma and MAPK Pathways (4 papers), Soft tissue tumor case studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Rheumatology (461 citations), Oncology (792 citations), Radiology, Nuclear Medicine and Imaging (403 citations) and Otorhinolaryngology (71 citations). Robert A. Lefkowitz has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Chaya S. Moskowitz, Lawrence H. Schwartz, Jonathan Landa, Sinchun Hwang, Jingbo Zhang, David M. Panicek, David P. Kelsen, Murray F. Brennan, Michelle S. Ginsberg and Binsheng Zhao. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Computer Assisted Tomography, Skeletal Radiology and Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact